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IMAGES IN DERMATOLOGYErythematous papular rash with sparing of foldsKaterina Yale, BA,a Ashley N. Elsensohn, MD, MPH,b Jessica Shiu, MD, PhD,b Kyle Amber, MD,b and
Janellen Smith, MDb
Washington, DC and Irvine, CaliforniaA 48-year-old Jamaicanwoman presentedwith several months of pruritus and a diffuse, erythematous scaly rash
on the face, trunk, and extremities. At this time, there was no sparing of the folds. She was preemptively treated
with triamcinolone 0.1% ointment and oral prednisone, 10 mg, for atopic dermatitis or contact dermatitis with
minimal improvement. Laboratory values were significant for lymphocytosis and absolute eosinophilia. Biopsy
found an atypical lymphoid infiltrate in the papillary dermis and epidermis (Fig 1). Nine months after initial
presentation, the rash transformed into perifollicular red-brown papules that spared body folds and double-
coverage areas (Figs 2 to 4). No palmoplantar hyperkeratosis or nail changes were noted. Repeat biopsy findings135
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136 Yale et alwere again significant for an atypical lymphoid infiltrate in the papillary dermis and epidermis. Human T-cell
lymphotropic virus-1 results were negative.Question 1: What type of rash is manifested by
this patient?
A. Allergic contact dermatitis (ACD)
B. Papuloerythroderma of Ofuji (PEO)
C. Pityriasis rubra pilaris (PRP)
D. Drug eruption
E. Psoriasis
A. ACD e Incorrect. Although contact dermatitis
can spare skin folds, it is unlikely in a patient with
no history of atopy. Furthermore, chronic ACD will
have more scale and lichenification.1
B. PEO e Correct. First described by Ofuji in
1984, PEO is characterized by a pruritic, diffuse
erythroderma-like eruption formed by coalescence
of flat-topped, red-to-brown papules with a cobble-
stone-like appearance.2 The eruption typically
spares skin folds and creases, the ‘‘deck chair’’
sign. Other features of PEO seen in patients includes
axillary and inguinal lymphadenopathy and palmo-
plantar hyperkeratosis and or nail bed infarction.3
C. PRP e Incorrect. Although patients with PRP
have follicular hyperaccentuation, such as our pa-
tient, the rash typically has a predominant scale and
distinct orange-red color. The rash will also classi-
cally contain islands of sparing but will not spare
the skin folds.1
D. Drug eruption e Incorrect. Although drug
eruptions have nonspecific rashes, they typically
progress and resolve quickly. Our patient had a
chronic rash and no history of new or changing
medications.1
E. Psoriasis e Incorrect. Although psoriasis is the
most common underlying cause of erythroderma, it
rarely spares the skin folds. Additionally, patients
typically have a history of psoriasis, facial sparing,
and nail changes, such as oil-drop spots and nail
pits.1From the School of Medicine and Health Sciences, George
Washington University, Washington, DCa and the Department
of Dermatology, University of California, Irvine.b
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ated with this rash?
A. Cutaneous T-cell lymphoma (CTCL)
B. Kidney cancer
C. Gastric cancer
D. Non-Hodgkin lymphoma
E. Bladder cancer
A. CTCL e Correct. At least 10 cases of CTCL
manifesting as PEO have been reported in the
literature, with an additional 8 to 10 cases beginning
as PEO and later transforming into CTCL.3 Given
that CTCL is difficult to diagnose because of variable
presentation and histologic findings, patients with
PEO should be monitored for transformation many
years after their original diagnosis.3 Martinez-
Barranca et al4 described a case of PEO that trans-
formed into CTCL 7 years after the original diag-
nosis. A change in the rash size, texture, or pruritus
should prompt an new biopsy to look for CTCL.3
B. Kidney cancer e Incorrect. Kidney cancer was
associated with 1 case of PEO in Japan, but no
association has been made in the United States.3
C. Gastric cancer e Incorrect. Gastric cancer is the
second most common cancer associated with PEO.
Most of these cases have been reported in older,
Asian men.3 Given our patient is a Jamaican
woman, this cancer is less likely.
D. Non-Hodgkin lymphoma e Incorrect. Hema-
tologic neoplasms are the third most common can-
cer associated with PEO; however, there are less
than 5 cases of NHL associated with PEO in the
literature.3
E. Bladder cancer e Incorrect. One case of
bladder cancer associated with PEO has been
reported in Japan; however, no association has
been made in the United States.3JAAD Case Reports 2019;5:135-7.
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Yale et al 137Question 3: What histopathologic findings are
most commonly associated with this rash?
A. Hyperkeratosis and parakeratosis with a peri-
vascular infiltrate of lymphocytes and neutrophils
B. Foci of orthokeratosis alternating with para-
keratosis in vertical and horizontal directions
C. Dermal infiltration of lymphocytes, histiocytes,
and eosinophils
D. Spongiosis, acanthosis, and an eosinophilic
infiltrate
E. Nonspecific histopathologic changes, some-
times with eosinophils
A. Hyperkeratosis and parakeratosis with a peri-
vascular infiltrate of lymphocytes and neutrophils e
Incorrect. This would be the histopathology ex-
pected in a biopsy of psoriasis.5
B. Foci of orthokeratosis alternating with para-
keratosis in vertical and horizontal directions e
Incorrect. This is the histopathology of PRP.5
C. Dermal infiltration of lymphocytes, histiocytes,
and eosinophils e Correct. Patients with PEO
classically have dermal infiltrates consisting of lym-
phocytes (100%), histiocytes (87%), and eosinophils
(82%).3 Neutrophils and giant cells are present in
less than 5% of cases.3 In patients with mycosis
fungoides manifesting as PEO, the infiltrate willhave a high percentage of atypical lymphocytes, as
seen in our patient.3
D. Spongiosis, acanthosis, and an eosinophilic
infiltrate e Incorrect. This histopathology is usually
seen in either atopic or contact dermatitis.5 The
presence of eosinophils is more commonly seen in
atopic dermatitis.
E. Nonspecific histopathologic changes, some-
times with eosinophils e Incorrect. Drug eruptions
will have nonspecific histopathology on biopsy.5
Eosinophils may be present in some cases. Biopsy
will not help diagnose a drug eruption; however, it
may help rule out other rashes that would have
characteristic histopathologic findings.REFERENCES
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